Acquisition of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) Under Investigation for Investors
The acquisition of Vitae Pharmaceuticals Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), concerning whether the takeover of Vitae Pharmaceuticals Inc by Allergan plc is unfair.
View full press release